Differential regulation of natriuretic peptide receptor activity in vascular cells.
- 1 September 1994
- journal article
- abstracts
- Published by Wolters Kluwer Health in Hypertension
- Vol. 24 (3) , 329-338
- https://doi.org/10.1161/01.hyp.24.3.329
Abstract
We studied the regulation of the individual natriuretic peptide receptor subtypes by 12-O-tetradecanoylphorbol 13-acetate (TPA) and forskolin in cultured bovine aortic endothelial and smooth muscle cells. In cultured endothelial cells, 10(-8) mol/L TPA caused a reduction in atrial natriuretic peptide (ANP) receptor binding activity that was seen as early as 2 hours after the treatment and reached a maximum (88 +/- 3% of control) after 24 hours, whereas the inhibition of ANP-stimulated cyclic GMP (cGMP) accumulation peaked at 2 hours (62 +/- 13% of control) and returned to control levels after 12 hours. After 24 hours of forskolin (10(-4) mol/L) treatment, ANP binding activity fell to 47 +/- 6%, and cGMP accumulation was 52 +/- 11% of control. Northern blot analysis revealed that 10(-8) mol/L TPA suppressed natriuretic peptide C receptor transcript levels, and forskolin increased levels modestly after 24 hours of treatment. Natriuretic peptide A receptor transcript levels remained unchanged by either treatment. In cultured smooth muscle cells, 10(-8) mol/L TPA suppressed ANP binding activity and ANP-stimulated cGMP formation in a fashion similar to that seen in endothelial cells. TPA treatment also resulted in an inhibition of C-type natriuretic peptide-stimulated cGMP production (59 +/- 7% of control); however, this response persisted for as long as 24 hours after addition of the agonist. Treatment with 10(-4) mol/L forskolin produced a time-dependent inhibition of ANP binding activity and did not inhibit cGMP production stimulated by either ANP or C-type natriuretic peptide. In contrast to the effects seen with endothelial cells, TPA caused a dose-dependent stimulation of natriuretic peptide C receptor mRNA, whereas forskolin was inhibitory in smooth muscle cells. These results indicate that the effects of the kinase activators are a function of the individual receptor subtype as well as the cell in which it is expressed and imply a considerable degree of flexibility in the response to regulatory stimuli.Keywords
This publication has 36 references indexed in Scilit:
- Characterization of natriuretic peptide receptors in cultured cells.Hypertension, 1992
- Human C-type natriuretic peptide. Characterization of the gene and peptide.Hypertension, 1992
- Phorbol ester and atrial natriuretic peptide receptor response on vascular smooth muscle.Hypertension, 1992
- Endothelin inhibits the atrial natriuretic factor stimulated cGMP production by activating the protein kinase C in rat aortic smooth muscle cellsBiochemical and Biophysical Research Communications, 1992
- Glucocorticoids and atrial natriuretic factor receptors on vascular smooth muscle.Hypertension, 1990
- C-Type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brainBiochemical and Biophysical Research Communications, 1990
- Endothelium and control of vascular function. State of the Art lecture.Hypertension, 1989
- Brain natriuretic peptide is a novel cardiac hormoneBiochemical and Biophysical Research Communications, 1989
- The presence of brain natriuretic peptide of 12,000 daltons in porcine heartBiochemical and Biophysical Research Communications, 1988
- Heterologous down-regulation of vascular atrial natriuretic peptide receptors by phorbol estersBiochemical and Biophysical Research Communications, 1988